State Street® SPDR® S&P® Biotech ETF
XBI
NYSE Arca
| Weiss Ratings | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $162.38 | |||
| Company Info | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | State Street Investment Management | |||
| Manager/Tenure (Years) | Karl A. Schneider (11), Raymond Donofrio (9), Emiliano Rabinovich (0) | |||
| Website | http://statestreet.com/im | |||
| Phone Number | 617-664-7338 | |||
| Fund Information | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | State Street® SPDR® S&P® Biotech ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jan 31, 2006 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.39% | |||
| Dividend | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.11% | |||
| Asset Allocation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.07% | |||
| Stock | 99.93% | |||
| U.S. Stock | 96.54% | |||
| Non-U.S. Stock | 3.39% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.02% | |||
| 30-Day Total Return | 9.68% | |||
| 60-Day Total Return | 2.53% | |||
| 90-Day Total Return | 18.82% | |||
| Year to Date Total Return | 33.21% | |||
| 1-Year Total Return | 81.43% | |||
| 2-Year Total Return | 61.58% | |||
| 3-Year Total Return | 105.85% | |||
| 5-Year Total Return | 23.76% | |||
| Price | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $162.38 | |||
| 1-Month Low Price | $147.01 | |||
| 1-Month High Price | $169.55 | |||
| 52-Week Low Price | $89.85 | |||
| 52-Week Low Price (Date) | Aug 29, 2025 | |||
| 52-Week High Price | $169.55 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| NAV | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $147.06 | |||
| 1-Month High NAV | $169.48 | |||
| 52-Week Low NAV | $89.87 | |||
| 52-Week Low NAV (Date) | Aug 29, 2025 | |||
| 52-Week High NAV | $169.48 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.10 | |||
| Standard Deviation | 26.07 | |||
| Balance Sheet | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 9.63B | |||
| Operating Ratios | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.35% | |||
| Turnover Ratio | 43.00% | |||
| Performance | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 54.03% | |||
| Last Bear Market Total Return | -17.46% | |||